article thumbnail

Modernizing Pharmacovigilance Outsourcing

XTalks

Companies outsource to gain access to specialized expertise and technology, scale pharmacovigilance (PV) activities, and reduce costs. However, the efficiency and effectiveness of externalized safety activities are below expectations for many biotech and pharma companies.

article thumbnail

Private equity firms play ‘pass the Parexel’ with $8.5bn handover deal

pharmaphorum

While the CRO category includes hundreds of small players, a handful of larger companies like, Parexel, PPD and others like Covance, ICON and Charles River Labs have grown into big multinational groups, often through serial acquisitions of their smaller counterparts.